Back to search
Degenerative Disc Disease (DDD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Degenerative Disc Disease (DDD) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Degenerative Disc Disease (DDD) trials you may qualify forA multi-center, prospective, dual arm, randomized, controlled pivotal study to evaluate the safety and effectiveness of the ReGelTec HYDRAFIL™ System.
This is a Phase III, randomized, double-blinded, Sham-controlled, multi-center study in subjects with single-level, symptomatic lumbar (L3- S1) intervertebral d…
Background Degenerative disc disease (DDD) is the leading cause of lower back pain and disability, which prevalence increasing with age. When conservative trea…
The goal of this observational study is to confirm the safety and performance of the three (3) Spinevision posterior fixations systems Lumis®, Plus® and Ulis® ,…
This study will be a prospective, open-label, multi-center study including 72 patients that will collect additional safety and efficacy data for the Spinal Stab…
The primary objective of this prospective, observational registry study is to evaluate the safety and effectiveness of Natural Matrix Protein® (NMP®) when used…
The goal of this clinical trial is to find out whether adding a bone-marrow aspirate concentrate (BMAC) injection during surgery can improve recovery in adults…
A study designed to treat patients with back pain associated with degenerative lumbar disc disease.